Testing effectiveness (Phase 2)Ended earlyNCT05986422
What this trial is testing
Methylprednisolone in Patients With Cognitive Deficits in Post-COVID-19 Syndrome (PCS)
Who this might be right for
Post-COVID-19 Syndrome
Charite University, Berlin, Germany 96